
Gsk Estructural India Private Limited
Constructs roads, bridges, tunnels, and subways.
Constructs roads, bridges, tunnels, and subways.
Gsk Estructural India Private Limited (GEIPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 August 2013 and has a history of 11 years and six months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Infrastructure And Utilities Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹1.85 Cr.
Rekha Veeramachaneni, Anil Gogineni, Seetha Veeramachaneni, and One other member serve as directors at the Company.
Hyderabad, Telangana, India
+91-XXXXXXXXXX
-
U45207TG2013PTC089396
089396
Private Limited Indian Non-Government Company
08 Aug 2013
30 Sep 2024
31 Mar 2024
Unlisted
Roc Hyderabad
Gsk Estructural India Private Limited offers a wide range of products and services, including Architectural & Civil Engineering, Civil Engineering Service, Road Construction, Commercial Construction Service, Commercial Building Contractors, Infrastructure Construction Service, Flyovers Construction Services, Construction Service, Irrigation Construction Service.
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rekha Veeramachaneni ![]() | Director | 08-Aug-2013 | Current |
Anil Gogineni ![]() | Director | 08-Aug-2013 | Current |
Seetha Veeramachaneni ![]() | Director | 08-Aug-2013 | Current |
Sai Gundapaneni ![]() | Director | 08-Aug-2013 | Current |
Gsk Estructural India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 1020.2% increase. The company also saw a substantial improvement in profitability, with a 696.55% increase in profit. The company's net worth Soared by an impressive increase of 19.41%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2021, Gsk Estructural India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
₹18.50 M
₹0
Date | Lender | Amount | Status |
---|---|---|---|
22 Sep 2014 | State Bank Of Hyderabad | ₹1.85 Cr | Open |
Unlock and access historical data on people associated with Gsk Estructural India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Gsk Estructural India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gsk Estructural India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Gsk Estructural India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Gsk Estructural India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
A charge with State Bank Of Hyderabad of Rs. 18.50 M registered on 22 Sep 2014 with Charge ID 10531344 was modified on 18 Dec 2015.
A charge with State Bank Of Hyderabad amounted to Rs. 18.50 M with Charge ID 10531344 was registered on 22 Sep 2014.
Rekha Veeramachaneni was appointed as a Director was appointed as a Director on 08 Aug 2013 & has been associated with this company since 11 years 6 months .
Anil Kumar Gogineni was appointed as a Director was appointed as a Director on 08 Aug 2013 & has been associated with this company since 11 years 6 months .
Gsk Estructural India Private Limited was incorporated on 08 Aug 2013.
The authorized share capital of Gsk Estructural India Private Limited is ₹ 2.00 M and paid-up capital is ₹ 2.00 M.
Currently 4 directors are associated with Gsk Estructural India Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Gsk Estructural India Private Limited is Plot No.31 2Nd Floor Phase-I, Kalyan Nagar India, Hyderabad, Telangana, 500038.
The corporate identification number (CIN) of Gsk Estructural India Private Limited is U45207TG2013PTC089396 and the company number is 089396 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2022, the revenue trend for Gsk Estructural India Private Limited has risen by 1020.20%.
The financial reports for the fiscal year 2022 indicates that The net worth of Gsk Estructural India Private Limited has experienced an upsurge of 19.41%.
As per the financial statements for fiscal Year 2022, The total open charges for Gsk Estructural India Private Limited amount to ₹ 1.85 Cr.
The most recent Balance Sheet for Gsk Estructural India Private Limited was filed with the ROC on 31 Mar 2024.